Rinucumab Biosimilar – Anti-PDGFRB, PDGFR-1, CD140b mAb – Research Grade

Reference:
Product nameRinucumab Biosimilar - Anti-PDGFRB, PDGFR-1, CD140b mAb - Research Grade
SourceCAS 1569263-06-4
SpeciesHomo sapiens
Expression systemMammalian cells
Purity>85%
BufferPBS buffer PH7.5
Delivery conditionBlue ice (+4°C)
Delivery Time3-5 days if in stock; 3-5 weeks if production needed
Storage conditionstore at -80°C
BrandProteoGenix
ApplicationsELISA,WB
Aliases /SynonymsRinucumab,REGN-2176,REGN-2176-3 (combination of aflibercept and ricunumab),REGN2176,PDGFRB, PDGFR-1, CD140b,anti-PDGFRB, PDGFR-1, CD140b
ReferencePX-TA1400
NoteFor research use only. Not suitable for clinical or therapeutic use.
IsotypeIgG4-kappa
ClonalityMonoclonal Antibody

Description of Rinucumab Biosimilar - Anti-PDGFRB/ PDGFR-1/CD140b mAb - Research Grade

General information on Anti-PDGFRB/ PDGFR-1/CD140b[Homo sapiens] (Rinucumab) Monoclonal Antibody

Rinucumab is investigated for the treatment of Neovascular (“Wet”) Age-related Macular Degeneration (AMD).

Reviews

There are no reviews yet.

REVIEW YOUR PRODUCT

Be the first to review “Rinucumab Biosimilar – Anti-PDGFRB, PDGFR-1, CD140b mAb – Research Grade”

Your email address will not be published. Required fields are marked *

Related products

Stable Isotope Labelled Rinucumab Biosimilar – Anti-PDGFRB/ PDGFR-1/CD140b mAb – Research Grade
SIL

Stable Isotope Labelled Rinucumab Biosimilar – Anti-PDGFRB/ PDGFR-1/CD140b mAb – Research Grade

PX-TA1400-SIL 15000€

Contact us

Got a question or need a quote?
Message us and we’ll get back to you 48 hours or less.






    Cart (0 Items)

    Your cart is currently empty.

    View Products